Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6605422.pdf
Reference23 articles.
1. Beemsterboer PM, de Koning HJ, Birnie E, van der Maas PJ, Schroder FH (1999) Advanced prostate cancer: course, care, and cost implications. Prostate 40: 97–104
2. Burkhardt JH, Litwin MS, Rose CM, Correa RJ, Sunshine JH, Hogan C, Hayman JA (2002) Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate cancer. J Clin Oncol 20: 2869–2875
3. Chelladurai AJ, Gunendran T, Nicholson C, Matanhelia SS, Blades RA (2008) The economic and workload impact of ‘backdoor’ prostate-specific antigen screening on the UK National Health Service: a single-centre experience. BJU Int 101: 289–292
4. Crawford ED, Abrahamsson PA (2008) PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Eur Urol 54: 262–273
5. Dong F, Kattan MW, Steyerberg EW, Jones JS, Stephenson AJ, Schroder FH, Klein EA (2008) Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice. J Urol 180: 150–154
Cited by 135 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MR Molecular Imaging of Extradomain-B Fibronectin for Assessing Progression and Therapy Resistance of Prostate Cancer;Chemical & Biomedical Imaging;2024-06-11
2. Effectiveness and Cost-effectiveness of Artificial Intelligence–assisted Pathology for Prostate Cancer Diagnosis in Sweden: A Microsimulation Study;European Urology Oncology;2024-05
3. Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam;European Urology;2024-01
4. Liquid Biomarkers in Prostate Cancer Diagnosis: Current Status and Emerging Prospects;The World Journal of Men's Health;2024
5. Der Arzt als gesundheitsökonomischer Akteur;Gesundheitsökonomie für Mediziner;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3